Cargando…
Update on COVID-19 Therapeutics for Solid Organ Transplant Recipients, Including the Omicron Surge
Major changes have occurred in therapeutics for coronavirus-19 (COVID-19) infection over the past 12–18 mo, most notably in early outpatient therapy. In most cases, solid organ transplant recipients were not included in the original clinical trials of these agents, so studies of real-world outcomes...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311293/ https://www.ncbi.nlm.nih.gov/pubmed/35700481 http://dx.doi.org/10.1097/TP.0000000000004200 |